J Gordon

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

Nicholas A. Kennedy, Graham Heap, Harry Green et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 655 citations · Full text

Inflammation, Active Luminal Crohn, Anti-tnf Treatment Failure +9

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease

Aleksejs Sazonovs, Nicholas A. Kennedy, Loukas Moutsianas et al. · Gastroenterology · 2019 · 385 citations · Full text

Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial

John G Williams, M Fasihul Alam, Laith Alrubaiy et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 250 citations · Full text

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial

Nurulamin M Noor, James Lee, Simon Bond et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 229 citations · Full text

Functional Modulation of Crohn’s Disease Myofibroblasts by Anti-Tumor Necrosis Factor Antibodies

Antonio Di Sabatino, Sylvia L. F. Pender, Claire Jackson et al. · Gastroenterology · 2007 · 153 citations · Full text

Inflammation, Chronic Inflammatory Diseases, Disease Myofibroblasts +10